NasdaqGM:AVDLPharmaceuticals
Did Avadel Pharmaceuticals’ (AVDL) Surprise Profitability Turn Just Shift Its Investment Narrative?
Avadel Pharmaceuticals plc recently reported earnings for the third quarter and nine months ended September 30, 2025, posting a net income of US$0.02 million and US$4.77 million for these periods respectively, compared to net losses a year ago.
This marks a turnaround for the company, with basic and diluted earnings per share from continuing operations improving from a US$0.46 loss to a US$0.05 profit year-over-year.
We'll explore how Avadel's swing to profitability this quarter could impact...